The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Headache
Cimicifuga Racemosa, Gelsemium Sempervirens, Rhus Tox · BLACK COHOSH 1 [hp_X]/mL; GELSEMIUM SEMPERVIRENS ROOT 8 [hp_X]/mL; TOXICODENDRON PUBESCENS LEAF 8 [hp_X]/mL · Liquid · Oral · Deseret Biologicals, Inc.
NDC 43742-1293-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cimicifuga Racemosa, Gelsemium Sempervirens, Rhus Tox (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Deseret Biologicals, Inc. | BLACK COHOSH 1 [hp_X]/mL; GELSEMIUM SEMPERVIRENS ROOT 8 [hp_X]/mL; TOXICODENDRON PUBESCENS LEAF 8 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Headache — NDC 43742-1293-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742129301.
Free to cite with attribution — see how the data is put together.